{"id":11564,"date":"2026-03-09T15:37:02","date_gmt":"2026-03-09T13:37:02","guid":{"rendered":"https:\/\/ir.epsilonnet.gr\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/"},"modified":"2026-03-09T15:37:02","modified_gmt":"2026-03-09T13:37:02","slug":"successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic","status":"publish","type":"post","link":"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/","title":{"rendered":"Successful Go-Live of the Galaxy Pharma Solution at NEWPHARM by EPSILON SINGULARLOGIC"},"content":{"rendered":"<p><a href=\"https:\/\/epsilon-singularlogic.eu\/\"><strong>EPSILON SINGULARLOGIC<\/strong><\/a>, a member of the <a href=\"https:\/\/epsilonnet.gr\/\"><strong>EPSILONNET Group<\/strong><\/a>, announces the successful go-live of the <a href=\"https:\/\/epsilon-singularlogic.eu\/products\/galaxy-pharma-suite\/\"><strong>Galaxy Pharma<\/strong><\/a> solution at <a href=\"https:\/\/newpharm.gr\/\"><strong>NEWPHARM<\/strong><\/a> as of <strong>November 1, 2025<\/strong>, completing another significant implementation in the pharmaceutical warehouse sector.<\/p>\n<p>NEWPHARM S.A., headquartered in Ioannina, is currently the largest private pharmaceutical warehouse and distribution center (3rd Party Logistics services provider) in Northwestern Greece. The company serves more than 650 pharmacies daily across the wider Epirus region, as well as the regional units of Corfu, Lefkada, Trikala, Larissa, Attica, Corinthia, Fthiotida, and Aetolia-Acarnania, through the wholesale distribution of pharmaceuticals, parapharmaceutical products, cosmetics, veterinary products, and a wide range of other medical devices.<\/p>\n<p>The project was particularly complex, as it included the integration of <strong>Galaxy Pharma<\/strong>, the comprehensive pharmaceutical warehouse management solution by <strong>EPSILON SINGULARLOGIC<\/strong> and <strong>EPSILON CSA<\/strong>, with WMS, B2B, SFA, and <strong>Knapp robotic systems<\/strong>. This integration enhances NEWPHARM\u2019s operational efficiency by covering all business operations within a unified environment and providing advanced tools for monitoring, integration, and process optimization.<\/p>\n<p>The successful production launch at NEWPHARM confirms the steady pace of Galaxy Pharma implementations within the sector, further strengthening the solution\u2019s footprint in the Greek pharmaceutical warehouse market.<\/p>\n<p><strong><em>Giannis Filippou<\/em><\/strong><em>, <strong>General Manager Integrator at EPSILON SINGULARLOGIC<\/strong>, stated: \u201cThe production launch at NEWPHARM confirms the ability of Galaxy Pharma to enhance the efficiency of pharmaceutical warehouses, accelerating distribution processes and improving business continuity. By integrating specialized infrastructures and automation systems, Galaxy Pharma acts as a key tool for digital upgrading in the sector, creating real value in the daily operations of pharmaceutical warehouses. This project is a characteristic example of a highly complex implementation, incorporating multiple subsystems and technologies, confirming the role of Galaxy Pharma as a catalyst for digital transformation in the pharmaceutical sector.\u201d<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Similarly, <strong>Christos Lanis, General Manager of NEWPHARM<\/strong>, stated: <em>\u201cAt NEWPHARM, for the past 27 years, we have been committed to continuous development, exceptional quality, reliability, and consistency for pharmacists and our customers. In this context, selecting a strategic partner for our digital transformation was a one-way path. EPSILON SINGULARLOGIC and Galaxy Pharma have proven to be the choice that will lead us successfully to our digital upgrade, always standing by our side.\u201d<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>EPSILON SINGULARLOGIC, a member of the EPSILONNET Group, announces the successful go-live of the Galaxy Pharma solution at NEWPHARM as of November 1, 2025, completing another significant implementation in the pharmaceutical warehouse sector. NEWPHARM S.A., headquartered in Ioannina, is currently the largest private pharmaceutical warehouse and distribution center (3rd Party Logistics services provider) in Northwestern [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-11564","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Successful Go-Live of the Galaxy Pharma Solution at NEWPHARM by EPSILON SINGULARLOGIC - Epsilon \u039det Investors Relations<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Successful Go-Live of the Galaxy Pharma Solution at NEWPHARM by EPSILON SINGULARLOGIC - Epsilon \u039det Investors Relations\" \/>\n<meta property=\"og:description\" content=\"EPSILON SINGULARLOGIC, a member of the EPSILONNET Group, announces the successful go-live of the Galaxy Pharma solution at NEWPHARM as of November 1, 2025, completing another significant implementation in the pharmaceutical warehouse sector. NEWPHARM S.A., headquartered in Ioannina, is currently the largest private pharmaceutical warehouse and distribution center (3rd Party Logistics services provider) in Northwestern [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/\" \/>\n<meta property=\"og:site_name\" content=\"Epsilon \u039det Investors Relations\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/OmilosEpsilonNet\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-09T13:37:02+00:00\" \/>\n<meta name=\"author\" content=\"Epsilon Net\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Epsilon Net\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/\"},\"author\":{\"name\":\"Epsilon Net\",\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/#\/schema\/person\/5f80764ac6044ebf50f026aed2df1386\"},\"headline\":\"Successful Go-Live of the Galaxy Pharma Solution at NEWPHARM by EPSILON SINGULARLOGIC\",\"datePublished\":\"2026-03-09T13:37:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/\"},\"wordCount\":375,\"publisher\":{\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/#organization\"},\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/\",\"url\":\"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/\",\"name\":\"Successful Go-Live of the Galaxy Pharma Solution at NEWPHARM by EPSILON SINGULARLOGIC - Epsilon \u039det Investors Relations\",\"isPartOf\":{\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/#website\"},\"datePublished\":\"2026-03-09T13:37:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ir.epsilonnet.gr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Successful Go-Live of the Galaxy Pharma Solution at NEWPHARM by EPSILON SINGULARLOGIC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/#website\",\"url\":\"https:\/\/ir.epsilonnet.gr\/en\/\",\"name\":\"Epsilon \u039det Investors Relations\",\"description\":\"Epsilon \u039det \u03a0\u03bb\u03b7\u03c1\u03bf\u03c6\u03cc\u03c1\u03b7\u03c3\u03b7 \u0395\u03c0\u03b5\u03bd\u03b4\u03c5\u03c4\u03ce\u03bd\",\"publisher\":{\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ir.epsilonnet.gr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/#organization\",\"name\":\"Epsilon \u039det Investors Relations\",\"url\":\"https:\/\/ir.epsilonnet.gr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ir.epsilonnet.gr\/wp-content\/uploads\/2022\/03\/logo-epsilonnet-classic.svg\",\"contentUrl\":\"https:\/\/ir.epsilonnet.gr\/wp-content\/uploads\/2022\/03\/logo-epsilonnet-classic.svg\",\"width\":201,\"height\":107,\"caption\":\"Epsilon \u039det Investors Relations\"},\"image\":{\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/OmilosEpsilonNet\",\"https:\/\/www.youtube.com\/user\/EpsilonNetOfficial\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/#\/schema\/person\/5f80764ac6044ebf50f026aed2df1386\",\"name\":\"Epsilon Net\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ir.epsilonnet.gr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a275861778033593a55022b5b82487661e1d83ae063a863bd9173b63e6886a68?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a275861778033593a55022b5b82487661e1d83ae063a863bd9173b63e6886a68?s=96&d=mm&r=g\",\"caption\":\"Epsilon Net\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Successful Go-Live of the Galaxy Pharma Solution at NEWPHARM by EPSILON SINGULARLOGIC - Epsilon \u039det Investors Relations","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/","og_locale":"en_US","og_type":"article","og_title":"Successful Go-Live of the Galaxy Pharma Solution at NEWPHARM by EPSILON SINGULARLOGIC - Epsilon \u039det Investors Relations","og_description":"EPSILON SINGULARLOGIC, a member of the EPSILONNET Group, announces the successful go-live of the Galaxy Pharma solution at NEWPHARM as of November 1, 2025, completing another significant implementation in the pharmaceutical warehouse sector. NEWPHARM S.A., headquartered in Ioannina, is currently the largest private pharmaceutical warehouse and distribution center (3rd Party Logistics services provider) in Northwestern [&hellip;]","og_url":"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/","og_site_name":"Epsilon \u039det Investors Relations","article_publisher":"https:\/\/www.facebook.com\/OmilosEpsilonNet","article_published_time":"2026-03-09T13:37:02+00:00","author":"Epsilon Net","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Epsilon Net","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/#article","isPartOf":{"@id":"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/"},"author":{"name":"Epsilon Net","@id":"https:\/\/ir.epsilonnet.gr\/en\/#\/schema\/person\/5f80764ac6044ebf50f026aed2df1386"},"headline":"Successful Go-Live of the Galaxy Pharma Solution at NEWPHARM by EPSILON SINGULARLOGIC","datePublished":"2026-03-09T13:37:02+00:00","mainEntityOfPage":{"@id":"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/"},"wordCount":375,"publisher":{"@id":"https:\/\/ir.epsilonnet.gr\/en\/#organization"},"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/","url":"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/","name":"Successful Go-Live of the Galaxy Pharma Solution at NEWPHARM by EPSILON SINGULARLOGIC - Epsilon \u039det Investors Relations","isPartOf":{"@id":"https:\/\/ir.epsilonnet.gr\/en\/#website"},"datePublished":"2026-03-09T13:37:02+00:00","breadcrumb":{"@id":"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ir.epsilonnet.gr\/en\/2026\/03\/successful-go-live-of-the-galaxy-pharma-solution-at-newpharm-by-epsilon-singularlogic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ir.epsilonnet.gr\/en\/"},{"@type":"ListItem","position":2,"name":"Successful Go-Live of the Galaxy Pharma Solution at NEWPHARM by EPSILON SINGULARLOGIC"}]},{"@type":"WebSite","@id":"https:\/\/ir.epsilonnet.gr\/en\/#website","url":"https:\/\/ir.epsilonnet.gr\/en\/","name":"Epsilon \u039det Investors Relations","description":"Epsilon \u039det \u03a0\u03bb\u03b7\u03c1\u03bf\u03c6\u03cc\u03c1\u03b7\u03c3\u03b7 \u0395\u03c0\u03b5\u03bd\u03b4\u03c5\u03c4\u03ce\u03bd","publisher":{"@id":"https:\/\/ir.epsilonnet.gr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ir.epsilonnet.gr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ir.epsilonnet.gr\/en\/#organization","name":"Epsilon \u039det Investors Relations","url":"https:\/\/ir.epsilonnet.gr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ir.epsilonnet.gr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ir.epsilonnet.gr\/wp-content\/uploads\/2022\/03\/logo-epsilonnet-classic.svg","contentUrl":"https:\/\/ir.epsilonnet.gr\/wp-content\/uploads\/2022\/03\/logo-epsilonnet-classic.svg","width":201,"height":107,"caption":"Epsilon \u039det Investors Relations"},"image":{"@id":"https:\/\/ir.epsilonnet.gr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/OmilosEpsilonNet","https:\/\/www.youtube.com\/user\/EpsilonNetOfficial"]},{"@type":"Person","@id":"https:\/\/ir.epsilonnet.gr\/en\/#\/schema\/person\/5f80764ac6044ebf50f026aed2df1386","name":"Epsilon Net","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ir.epsilonnet.gr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a275861778033593a55022b5b82487661e1d83ae063a863bd9173b63e6886a68?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a275861778033593a55022b5b82487661e1d83ae063a863bd9173b63e6886a68?s=96&d=mm&r=g","caption":"Epsilon Net"}}]}},"_links":{"self":[{"href":"https:\/\/ir.epsilonnet.gr\/en\/wp-json\/wp\/v2\/posts\/11564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ir.epsilonnet.gr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ir.epsilonnet.gr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ir.epsilonnet.gr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ir.epsilonnet.gr\/en\/wp-json\/wp\/v2\/comments?post=11564"}],"version-history":[{"count":0,"href":"https:\/\/ir.epsilonnet.gr\/en\/wp-json\/wp\/v2\/posts\/11564\/revisions"}],"wp:attachment":[{"href":"https:\/\/ir.epsilonnet.gr\/en\/wp-json\/wp\/v2\/media?parent=11564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ir.epsilonnet.gr\/en\/wp-json\/wp\/v2\/categories?post=11564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ir.epsilonnet.gr\/en\/wp-json\/wp\/v2\/tags?post=11564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}